Investor Presentation on Unaudited Financial Results for the quarter and half year ended September 30, 2026

Ref: 47/SE/LC/2026-27 Date: November 4, 2026 Scrip Code BSE: 544122 NSE: ENTERO ISIN: INE010601016 Head, Listing Compliance Department Head, Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, G Block, Dalal Street, Mumbai - 400001 Bandra -Kurla Complex, Bandra (East), Mumbai- 400051 Dear Sir/Madam, Subject: Investor Presentation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Investor Presentation on Unaudited Financial Results for the quarter and half year ended September 30, 2026. The above-mentioned Investor Presentation will also be available on website of the Company at www.enterohealthcare.com This is for your information and records. Yours Faithfully, For Entero Healthcare Solutions Limited Sanu Kapoor Vice President- Group General Counsel, Company Secretary & Compliance Officer Encl: As above 239 199 Everything in Pharma… Everywhere in India… 194 Entero Healthcare Solutions Limited Q2FY27 Investor Presentation – November 2026 Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Entero Healthcare Solutions Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company’s future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cash flows, the Company’s market preferences and its exposure to market risks, as well as other risks. The Company’s actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and the Company is not responsible for such third-party statements and projections. 239 199 Q2 FY27 Financial Highlights Management Commentary We continued the strong organic growth momentum outpacing industry growth and sustained improvement in EBITDA margin in the second quarter. Our revenue grew by 34.7% YoY (LFL) with EBITDA margin at 5.3%. We are pleased with the performance in first half of the year and are on track to deliver comfortably against our full year guidance. Prabhat Agrawal Promoter, MD and CEO H1FY27 - Key Financial Highlights › Revenue growth on LFL basis was 37.2% YoY. Organic revenue growth on LFL basis was 19.8% YoY. Like-for-Like growth includes impact of revenue recorded on net margin basis and divestment of a subsidiary › Reported revenue growth was 35.4% YoY. Organic revenue growth was 18.0% YoY and Inorganic growth was 17.4%, entirely on account of calendarisation › Gross margin improved by 136bps YoY to 11.5% › EBITDA Margin improved by 139bps YoY to 5.2% › PAT Margin was 2.8% › NWC days at 66 days (vs 68 days in H1FY26) › Operating Cashflow at Rs. (46.5) Cr due to timing in trade receivables on certain government contracts. Collection has been received in November. Adjusted for this collection on due date, H1FY27 operating cashflow would have been positive › ROCE at 21.8%. ROE was 21.3% › No new acquisitions done in the first-half; organic growth ran ahead of IPM growth, moderated by the conscious exit from certain low-margin businesses Q2FY27 - Key Financial Highlights › Revenue growth on LFL basis was 34.7% YoY. Organic revenue growth on LFL basis was 20.0% YoY. Like-for-Like growth includes impact of revenue recorded on net margin basis and divestment of a subsidiary › Reported revenue growth was 32.9% YoY. Organic revenue growth was 18.2% YoY and Inorganic growth was 14.7%, entirely on account of calendarisation › Gross margin improved by 126bps YoY to 11.5% › EBITDA Margin improved by 135bps YoY to 5.3% › PAT Margin was 2.9% › NWC days at 64 days (from 61 days in Q1FY27). NWC impacted due to timing in trade receivables on a contract › ROCE improved to 22.0% from 21.1% in Q1FY27. ROE was 22.4% vs 20.4% in Q1FY27 › No new acquisitions done during the quarter; organic growth ran ahead of IPM growth, moderated by the conscious exit from certain low-margin businesses Revenue Split +32.9% +14.7% 2,087 +18.2% 1,571 Q2FY26 Revenue Organic Growth Calendarisation New Acquisitions Q2FY27 Revenue Particulars Q1FY26 Q2FY26 Q3FY26 Q4FY26 FY26 Q1FY27 Q2FY27 H1FY27 Organic Growth 12.0% 10.7% 14.2% 16.6% 13.4% 17.8% 18.2% 18.0% Organic growth - LFL 15.0% 13.4% 17.1% 17.1% 15.6% 19.6% 20.0% 19.8% vs IPM growth 1.7x 1.8x 1.4x 1.4x 1.6x 1.4x 1.3x 1.4x 233 Inorganic Growth 16.4% 10.0% 11.4% 26.0% 16.0% 20.4% 14.7% 17.4% o/w Calendarisation 16.4% 6.3% 0.6% 0.0% 5.3% 20.4% 14.7% 17.4% o/w New Acquisition - 3.8% 10.7% 26.0% 10.7% NA NA NA Total Growth 28.0% 21.0% 25.6% 42.6% 29.3% 38.2% 32.9% 35.4% Total Growth - LFL 31.4% 23.4% 28.5% 43.1% 31.5% 40.0% 34.7% 37.2% Like-for-Like growth includes impact of revenue recorded on net margin basis and divestment of a subsidiary Consolidated Financial Highlights Revenue (Rs. Cr) Gross Profit (Rs. Cr) & Margin (%) EBITDA (Rs. Cr) & Margin (%) PAT (Rs. Cr) 239 +33% +49% +78% +66% 2,087 240 111 61 r a 1,571 23 u 161 Q 62 37 11.5% 215 10.2% 5.3% 4.0% 2.9% 2.3% Q2FY26 Q2FY27 Q2FY26 Q2FY27 Q2FY26 Q2FY27 Q2FY26 Q2FY27 Revenue (Rs. Cr) Gross Profit (Rs. Cr) & Margin (%) EBITDA (Rs. Cr) & Margin (%) PAT (Rs. Cr) +35% +54% +85% +69% lr 4,028 461 208 113 2,975 la 300 0 H 112 67 11.5% 10.1% 5.2% 196 2.8% 3.8% 2.2% H1FY26 H1FY27 H1FY26 H1FY27 H1FY26 H1FY27 H1FY26 H1FY27 Consolidated Profit & Loss Statement Particulars (Rs. Cr) Q2FY27 Q1FY27 Q2FY26 YoY% H1FY27 H1FY26 YoY% Revenue 2,087.1 1,940.5 1,570.9 33% 4,027.6 2,974.8 35% Cost of Goods Sold 1,847.1 1,719.1 1,410.1 3,566.2 2,674.4 Gross Profit 240.0 221.4 160.8 49% 461.3 300.4 54% Gross Margin (%) 11.5% 11.4% 10.2% 126bps 11.5% 10.1% 136bps Employee Expenses 69.8 68.7 58.2 138.5 114.9 23 ESOP Expenses 0.9 0.8 1.0 1.7 1.9 143 Other Expenses 58.6 55.0 39.5 113.5 71.5 215 EBITDA 110.7 97.0 62.1 78% 207.7 112.1 85% EBITDA Margin (%) 5.3% 5.0% 4.0% 135bps 5.2% 3.8% 139bps Other Income 3.7 2.7 4.6 6.4 10.2 Lease Rental related [Showing first 8,000 characters — download PDF for full document]